10x Genomics launched Atera at AACR, positioning the in situ spatial biology platform for whole-transcriptome analysis at high throughput. The company said Atera can image multiple slides per run, supports whole-transcriptome assays, and includes cloud tools for storing and analyzing spatial biology datasets. 10x described Atera as designed to reduce tradeoffs seen in current platforms by combining assay chemistry, fluidics, optics, and computational performance. The firm also cited shipping plans beginning in the second half of the year and listed pricing for the instrument and reagent costs. The announcement is likely to intensify competition in spatial biology instrumentation, where researchers are increasingly demanding higher throughput without sacrificing single-cell resolution.